0.08Open0.08Pre Close0 Volume41 Open Interest22.50Strike Price0.00Turnover0.00%IV123.34%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.08Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma126.38Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Vir Biotechnology Stock Discussion
They don't simply give such a high price target for nothing.
$Vir Biotechnology (VIR.US)$
Congratulations to trader who have bought it on premarket for day trade profit.
Market is going downtrend for the incoming fed announcement. Lock on profit today as tomorrow market will be closed.
Today good opportunity to swing trade $ $Sana Biotechnology (SANA.US)$ $Absci Corp (ABSI.US)$
Pick the right momentum stock to trade for profit.
Follow me, follow momentum
Vir Biotechnology Is Presenting Initial Phase 1 Data From Two Of Its Dual-masked T-cell Engagers (TCEs): VIR-5818, Targeting A Variety Of HER2-expressing Solid Tumors; And VIR-5500, Targeting PSMA In Metastatic Castration-resistant Prostate Cancer
Vir Biotechnology Inc - Vir-5818 Shows 50% Tumor Shrinkage in Her2 Cancers at ≥400 ΜG/Kg
No comment yet